The use of certolizumab pegol to successfully treat generalized pustular psoriasis combined with psoriatic uveitis
J Dermatol
.
2023 Jun;50(6):e175-e176.
doi: 10.1111/1346-8138.16704.
Epub 2022 Dec 30.
Authors
Kazuki Yatsuzuka
1
,
Takuya Matsumoto
2
,
Yuri Sakane
3
,
Ryo Fukaura
4
,
Takuya Takeichi
4
,
Masashi Akiyama
4
,
Masamoto Murakami
1
Affiliations
1
Department of Dermatology, Ehime University Graduate School of Medicine, Ehime, Japan.
2
Department of Hematology, Clinical Immunology and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan.
3
Department of Ophthalmology, Ehime University Graduate School of Medicine, Ehime, Japan.
4
Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
PMID:
36585757
DOI:
10.1111/1346-8138.16704
No abstract available
Publication types
Letter
MeSH terms
Arthritis, Psoriatic*
Certolizumab Pegol / therapeutic use
Exanthema*
Humans
Psoriasis* / complications
Psoriasis* / diagnosis
Psoriasis* / drug therapy
Uveitis* / complications
Uveitis* / drug therapy
Substances
Certolizumab Pegol